September marks the two-year anniversary of the FDA’s Zantac recall. As you may remember from the news, an independent pharmacy linked Zantac to NDMA, a cancer-causing chemical. The cases are still proceeding in the multi-district litigation (MDL) but no trials have been scheduled as of yet. We are hopeful that will occur late this year or early in 2022.
So, it’s not too late to join the lawsuit. If you used the product for at least six months and were diagnosed with certain types of cancer, there may be a claim for financial compensation. Call us today at (866) BAD-RXRX, (866) 223-7979 to see if you are eligible. The consultation is free. What do you have to lose?